☰

Joost Smolders, M.D./Ph.D. - Publications

Affiliations: 
2007-2011 Experimental Immunology. Academic MS Center Maastricht University Medical Center+ 
 2011-2012 Neuroimmunology Netherlands Institute for Neuroscience, Amsterdam, NL 
 2012-2013 Neurology St Antonius Ziekenhuis 
 2013-2014 Neurology Radboud University Medical Center 
 2014- Neurology Canisius Wilhelmina Ziekenhuis 
Area:
Multiple Sclerosis, neuroscience, immunology, vitamin D
Tree Info Grants Similar researchers PubMed Report error

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 van den Bosch AMR, van der Poel M, Fransen NL, Vincenten MCJ, Bobeldijk AM, Jongejan A, Engelenburg HJ, Moerland PD, Smolders J, Huitinga I, Hamann J. Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation. Nature Communications. 15: 1667. PMID 38396116 DOI: 10.1038/s41467-024-46068-3  0.32
2023 Blok KM, van Rosmalen J, Tebayna N, Smolders J, Wokke B, de Beukelaar J. Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis. Frontiers in Neurology. 14: 1277477. PMID 38020591 DOI: 10.3389/fneur.2023.1277477  0.301
2023 Hoeks C, Puijfelik FV, Koetzier SC, Rip J, Corsten CEA, Wierenga-Wolf AF, Melief MJ, Stinissen P, Smolders J, Hellings N, Broux B, van Luijn MM. Differential Runx3, Eomes, and T-bet expression subdivides MS-associated CD4 T cells with brain-homing capacity. European Journal of Immunology. e2350544. PMID 38009648 DOI: 10.1002/eji.202350544  0.312
2023 Bogers L, Engelenburg HJ, Janssen M, Unger PA, Melief MJ, Wierenga-Wolf AF, Hsiao CC, Mason MRJ, Hamann J, van Langelaar J, Smolders J, van Luijn MM. Selective emergence of antibody-secreting cells in the multiple sclerosis brain. Ebiomedicine. 89: 104465. PMID 36796230 DOI: 10.1016/j.ebiom.2023.104465  0.325
2022 Rijvers L, van Langelaar J, Bogers L, Melief MJ, Koetzier SC, Blok KM, Wierenga-Wolf AF, de Vries HE, Rip J, Corneth OB, Hendriks RW, Grenningloh R, Boschert U, Smolders J, van Luijn MM. Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib. Jci Insight. 7. PMID 35852869 DOI: 10.1172/jci.insight.160909  0.346
2022 Koetzier SC, van Langelaar J, Wierenga-Wolf AF, Melief MJ, Pol K, Musters S, Lubberts E, Dik WA, Smolders J, van Luijn MM. Improving Glucocorticoid Sensitivity of Brain-Homing CD4 T Helper Cells by Steroid Hormone Crosstalk. Frontiers in Immunology. 13: 893702. PMID 35693770 DOI: 10.3389/fimmu.2022.893702  0.46
2021 Mimpen M, Rolf L, Poelmans G, van den Ouweland J, Hupperts R, Damoiseaux J, Smolders J. Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis. Plos One. 16: e0261097. PMID 34855907 DOI: 10.1371/journal.pone.0261097  0.736
2021 Mimpen M, Damoiseaux J, van Doorn W, Rolf L, Muris AH, Hupperts R, van Luijn MM, Gerlach O, Smolders J. Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients. Journal of Neuroimmunology. 358: 577664. PMID 34280843 DOI: 10.1016/j.jneuroim.2021.577664  0.712
2021 Koetzier SC, Neuteboom RF, Wierenga-Wolf AF, Melief MJ, de Mol CL, van Rijswijk A, Dik WA, Broux B, van der Wal R, van den Berg SAA, Smolders J, van Luijn MM. Effector T Helper Cells Are Selectively Controlled During Pregnancy and Related to a Postpartum Relapse in Multiple Sclerosis. Frontiers in Immunology. 12: 642038. PMID 33790911 DOI: 10.3389/fimmu.2021.642038  0.311
2021 Smolders J, Hiller A, Camu W. Editorial: Vitamin D in Neurological Diseases: From Pathophysiology to Therapy. Frontiers in Neurology. 12: 614900. PMID 33767657 DOI: 10.3389/fneur.2021.614900  0.413
2021 Mimpen M, Rolf L, Muris AH, Gerlach O, Poelmans G, Hupperts R, Smolders J, Damoiseaux J. NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis. Journal of Neuroimmunology. 353: 577499. PMID 33529846 DOI: 10.1016/j.jneuroim.2021.577499  0.568
2020 Mimpen M, Muris AH, Rolf L, Gerlach O, Kuhle J, Hupperts R, Smolders J, Damoiseaux J. Prognostic value of NK cell/ T cell ratios for disease activity in multiple sclerosis. European Journal of Neurology. PMID 33326677 DOI: 10.1111/ene.14680  0.605
2020 Smolders J, van den Ouweland J, Geven C, Pickkers P, Kox M. Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence. Metabolism: Clinical and Experimental. 154434. PMID 33217408 DOI: 10.1016/j.metabol.2020.154434  0.473
2020 Koetzier SC, van Langelaar J, Blok KM, van den Bosch TPP, Wierenga-Wolf AF, Melief MJ, Pol K, Siepman TA, Verjans GMGM, Smolders J, Lubberts E, de Vries HE, van Luijn MM. Brain-homing CD4 T cells display glucocorticoid-resistant features in MS. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 33037101 DOI: 10.1212/NXI.0000000000000894  0.31
2020 Hsiao CC, Fransen NL, van den Bosch AMR, Brandwijk KIM, Huitinga I, Hamann J, Smolders J. White matter lesions in multiple sclerosis are enriched for CD20 CD8 tissue-resident memory T cells. European Journal of Immunology. PMID 32949467 DOI: 10.1002/Eji.202048665  0.31
2020 Smolders J, Fransen NL, Hsiao CC, Hamann J, Huitinga I. Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis. Expert Review of Neurotherapeutics. PMID 32476499 DOI: 10.1080/14737175.2020.1776609  0.433
2020 van Langelaar J, Rijvers L, Smolders J, van Luijn MM. B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers. Frontiers in Immunology. 11: 760. PMID 32457742 DOI: 10.3389/Fimmu.2020.00760  0.443
2020 Bruijstens AL, Blok KM, Smolders J, Wokke BH, Neuteboom RF. Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520921367. PMID 32406801 DOI: 10.1177/1352458520921367  0.429
2020 Fransen NL, Hsiao CC, van der Poel M, Engelenburg HJ, Verdaasdonk K, Vincenten MCJ, Remmerswaal EBM, Kuhlmann T, Mason MRJ, Hamann J, Smolders J, Huitinga I. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. Brain : a Journal of Neurology. PMID 32400866 DOI: 10.1093/Brain/Awaa117  0.35
2020 Mimpen M, Smolders J, Hupperts R, Damoiseaux J. Natural killer cells in multiple sclerosis: A review. Immunology Letters. 222: 1-11. PMID 32113900 DOI: 10.1016/J.Imlet.2020.02.012  0.636
2019 Smolders J, Torkildsen Ø, Camu W, Holmøy T. An Update on Vitamin D and Disease Activity in Multiple Sclerosis. Cns Drugs. PMID 31686407 DOI: 10.1007/S40263-019-00674-8  0.629
2019 Smolders J, Damoiseaux J, Hupperts R. Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis. Brain : a Journal of Neurology. PMID 31665228 DOI: 10.1093/Brain/Awz339  0.732
2019 Smolders J, Mimpen M, Oechtering J, Damoiseaux J, van den Ouweland J, Hupperts R, Kuhle J. Vitamin D supplementation and neurofilament light chain in multiple sclerosis. Acta Neurologica Scandinavica. PMID 31657006 DOI: 10.1111/Ane.13185  0.721
2019 Hupperts R, Smolders J, Vieth R, Holmøy T, Marhardt K, Schluep M, Killestein J, Barkhof F, Beelke M, Grimaldi LME. Randomized trial of daily high-dose vitamin D in patients with RRMS receiving subcutaneous interferon β-1a. Neurology. PMID 31594857 DOI: 10.1212/Wnl.0000000000008445  0.673
2019 Fransen NL, Crusius JBA, Smolders J, Mizee MR, van Eden CG, Luchetti S, Remmerswaal EBM, Hamann J, Mason MRJ, Huitinga I. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathology (Zurich, Switzerland). PMID 31228212 DOI: 10.1111/Bpa.12760  0.387
2018 Rolf L, Smolders J, van den Ouweland J, Hupperts R, Damoiseaux J. Correlation of different cellular assays to analyze T cell-related cytokine profiles in vitamin D-supplemented patients with multiple sclerosis. Molecular Immunology. 105: 198-204. PMID 30550982 DOI: 10.1016/J.Molimm.2018.12.001  0.678
2018 Smolders J, Heutinck KM, Fransen NL, Remmerswaal EBM, Hombrink P, Ten Berge IJM, van Lier RAW, Huitinga I, Hamann J. Tissue-resident memory T cells populate the human brain. Nature Communications. 9: 4593. PMID 30389931 DOI: 10.1038/S41467-018-07053-9  0.311
2018 Rolf L, Damoiseaux J, Huitinga I, Kimenai D, van den Ouweland J, Hupperts R, Smolders J. Stress-Axis Regulation by Vitamin D in Multiple Sclerosis. Frontiers in Neurology. 9: 263. PMID 29755397 DOI: 10.3389/Fneur.2018.00263  0.748
2018 Damoiseaux J, Smolders J. The Engagement Between Vitamin D and the Immune System: Is Consolidation by a Marriage to Be Expected? Ebiomedicine. PMID 29685791 DOI: 10.1016/J.Ebiom.2018.04.013  0.544
2017 Rolf L, Muris AH, Theunissen R, Hupperts R, Damoiseaux J, Smolders J. Vitamin D3 supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances? Journal of Neuroimmunology. PMID 29153546 DOI: 10.1016/J.Jneuroim.2017.11.007  0.717
2017 Rolf L, Muris AH, Mathias A, Du Pasquier R, Koneczny I, Disanto G, Kuhle J, Ramagopalan S, Damoiseaux J, Smolders J, Hupperts R. Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517722646. PMID 28731372 DOI: 10.1177/1352458517722646  0.732
2017 Smolders J, Rolf L, Damoiseaux J, Hupperts R. On the ethics of not supplementing low 25-hydroxyvitamin D levels in a controlled study in relapsing remitting multiple sclerosis. Journal of the Neurological Sciences. PMID 28629873 DOI: 10.1016/J.Jns.2017.06.009  0.717
2017 Rolf L, Muris AH, Bol Y, Damoiseaux J, Smolders J, Hupperts R. Vitamin D3 supplementation in multiple sclerosis: Symptoms and biomarkers of depression. Journal of the Neurological Sciences. 378: 30-35. PMID 28566173 DOI: 10.1016/J.Jns.2017.04.017  0.724
2016 Muris AH, Smolders J, Rolf L, Thewissen M, Hupperts R, Damoiseaux J. Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study. Journal of Neuroimmunology. 300: 47-56. PMID 27806875 DOI: 10.1016/J.Jneuroim.2016.09.018  0.774
2016 Rolf L, Damoiseaux J, Hupperts R, Huitinga I, Smolders J. Network of nuclear receptor ligands in multiple sclerosis: Common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules. Autoimmunity Reviews. PMID 27395031 DOI: 10.1016/J.Autrev.2016.07.002  0.646
2016 Knippenberg S, Smolders J, van den Maegdenbergh M, Porro G, Damoiseaux J, Hupperts R. Vitamin D status is negatively correlated with retinal nerve fiber layer thickness in relapsing-remitting MS patients without acute optic neuritis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27301383 DOI: 10.1177/1352458516652950  0.657
2016 Muris AH, Smolders J, Rolf L, Klinkenberg LJ, van der Linden N, Meex S, Damoiseaux J, Hupperts R. Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up. Plos One. 11: e0156122. PMID 27276080 DOI: 10.1371/Journal.Pone.0156122  0.751
2016 Smolders J, Muris AH, Damoiseaux J. Immunomodulation by vitamin D in multiple sclerosis: More than IL-17. Journal of Neuroimmunology. 292: 79-80. PMID 26943962 DOI: 10.1016/J.Jneuroim.2016.01.017  0.565
2016 Berge T, Leikfoss IS, Brorson IS, Bos SD, Page CM, Gustavsen MW, Bjølgerud A, Holmøy T, Celius EG, Damoiseaux J, Smolders J, Harbo HF, Spurkland A. The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells. Genes and Immunity. 17: 118-27. PMID 26765264 DOI: 10.1038/Gene.2015.61  0.642
2015 Muris AH, Rolf L, Broen K, Hupperts R, Damoiseaux J, Smolders J. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis. The Journal of Steroid Biochemistry and Molecular Biology. PMID 26598277 DOI: 10.1016/J.Jsbmb.2015.11.009  0.726
2015 Peelen E, Muris AH, Damoiseaux J, Knippenberg S, Broens K, Smolders J, Cohen Tervaert JW, Hupperts R, Thewissen M. GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D. Journal of Neuroimmunology. 280: 36-42. PMID 25773153 DOI: 10.1016/J.Jneuroim.2015.02.007  0.67
2015 Peelen E, Damoiseaux J, Muris AH, Knippenberg S, Smolders J, Hupperts R, Thewissen M. Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis. Molecular Immunology. 63: 521-9. PMID 25458313 DOI: 10.1016/J.Molimm.2014.10.008  0.615
2014 Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 433-7. PMID 23959712 DOI: 10.1177/1352458513500552  0.756
2013 Melief J, Schuurman KG, van de Garde MD, Smolders J, van Eijk M, Hamann J, Huitinga I. Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed. Glia. 61: 1848-61. PMID 24014207 DOI: 10.1002/Glia.22562  0.461
2013 Smolders J, Remmerswaal EB, Schuurman KG, Melief J, van Eden CG, van Lier RA, Huitinga I, Hamann J. Characteristics of differentiated CD8(+) and CD4 (+) T cells present in the human brain. Acta Neuropathologica. 126: 525-35. PMID 23880787 DOI: 10.1007/S00401-013-1155-0  0.336
2013 Disanto G, Handel AE, Damoiseaux J, Hupperts R, Giovannoni G, Smolders J, Ramagopalan SV. Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1679-80. PMID 23828870 DOI: 10.1177/1352458513494494  0.706
2013 Peelen E, Thewissen M, Knippenberg S, Smolders J, Muris AH, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J. Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators. Journal of Neuroimmunology. 258: 77-84. PMID 23517930 DOI: 10.1016/J.Jneuroim.2013.02.014  0.66
2013 Smolders J, Schuurman KG, van Strien ME, Melief J, Hendrickx D, Hol EM, van Eden C, Luchetti S, Huitinga I. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. Journal of Neuropathology and Experimental Neurology. 72: 91-105. PMID 23334593 DOI: 10.1097/Nen.0B013E31827F4Fcc  0.615
2013 Verheul F, Smolders J, Trojano M, Lepore V, Zwanikken C, Amato MP, Grand'maison F, Butzkueven H, Marrosu M, Duquette P, Comi G, Izquierdo G, Grammond P, Lus G, Petersen T, et al. Fluctuations of MS births and UV-light exposure. Acta Neurologica Scandinavica. 127: 301-8. PMID 22970985 DOI: 10.1111/Ane.12007  0.622
2013 Muris AH, Smolders J, Damoiseaux J. Comment on the article by Allen et al. 'A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers'. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 510. PMID 22907942 DOI: 10.1177/1352458512457846  0.429
2012 Holmøy T, Kampman MT, Smolders J. Vitamin D in multiple sclerosis: implications for assessment and treatment. Expert Review of Neurotherapeutics. 12: 1101-12. PMID 23039389 DOI: 10.1586/Ern.12.99  0.614
2012 Muris AH, Damoiseaux J, Smolders J, Cohen Tervaert JW, Hupperts R, Thewissen M. Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited. Journal of Immunological Methods. 381: 59-65. PMID 22565155 DOI: 10.1016/J.Jim.2012.04.011  0.553
2012 Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 78: 841. PMID 22411961 DOI: 10.1212/01.Wnl.0000413180.13413.Ce  0.671
2012 Bol Y, Smolders J, Duits A, Lange IM, Romberg-Camps M, Hupperts R. Fatigue and heat sensitivity in patients with multiple sclerosis. Acta Neurologica Scandinavica. 126: 384-9. PMID 22404677 DOI: 10.1111/J.1600-0404.2012.01660.X  0.593
2012 Knippenberg S, Bol Y, Smolders J, Hupperts R, Damoiseaux J. Response: Relationship between vitamin D and depression in multiple sclerosis Acta Neurologica Scandinavica. 125: e26-e27. DOI: 10.1111/J.1600-0404.2011.01640.X  0.699
2011 Peelen E, Damoiseaux J, Smolders J, Knippenberg S, Menheere P, Tervaert JW, Hupperts R, Thewissen M. Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. Journal of Neuroimmunology. 240: 97-103. PMID 22035960 DOI: 10.1016/J.Jneuroim.2011.09.013  0.692
2011 Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission. Journal of Neuroimmunology. 239: 80-6. PMID 21940055 DOI: 10.1016/J.Jneuroim.2011.08.019  0.709
2011 Smolders J, Moen SM, Damoiseaux J, Huitinga I, Holmøy T. Vitamin D in the healthy and inflamed central nervous system: access and function. Journal of the Neurological Sciences. 311: 37-43. PMID 21862439 DOI: 10.1016/J.Jns.2011.07.033  0.652
2011 Knippenberg S, Smolders J, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J. Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1418-23. PMID 21690147 DOI: 10.1177/1352458511412655  0.741
2011 Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JW, Hupperts R, Damoiseaux J. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmunity Reviews. 10: 733-43. PMID 21621002 DOI: 10.1016/J.Autrev.2011.05.002  0.727
2011 Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial. Journal of the Neurological Sciences. 311: 44-9. PMID 21620416 DOI: 10.1016/J.Jns.2011.04.013  0.761
2011 Smolders J, Thewissen M, Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis. Journal of Neuroimmunology. 235: 91-7. PMID 21507492 DOI: 10.1016/J.Jneuroim.2011.03.012  0.723
2011 Smolders J, Damoiseaux J. Vitamin D as a T-cell modulator in multiple sclerosis. Vitamins and Hormones. 86: 401-28. PMID 21419282 DOI: 10.1016/B978-0-12-386960-9.00018-6  0.635
2011 Smolders J. Vitamin d and multiple sclerosis: correlation, causality, and controversy. Autoimmune Diseases. 2011: 629538. PMID 21188193 DOI: 10.4061/2011/629538  0.639
2011 Smolders J, Thewissen M, Damoiseaux J. Control of T cell activation by vitamin D. Nature Immunology. 12: 3; author reply 3-4. PMID 21169995 DOI: 10.1038/Ni0111-3A  0.571
2011 Knippenberg S, Bol Y, Damoiseaux J, Hupperts R, Smolders J. Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue. Acta Neurologica Scandinavica. 124: 171-5. PMID 20880265 DOI: 10.1111/J.1600-0404.2010.01447.X  0.707
2010 Smolders J, Peelen E, Thewissen M, Cohen Tervaert JW, Menheere P, Hupperts R, Damoiseaux J. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. Plos One. 5: e15235. PMID 21179201 DOI: 10.1371/Journal.Pone.0015235  0.77
2010 Smolders J, Menheere P, Thewissen M, Peelen E, Tervaert JW, Hupperts R, Damoiseaux J. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. The Journal of Steroid Biochemistry and Molecular Biology. 121: 243-6. PMID 20211254 DOI: 10.1016/J.Jsbmb.2010.03.001  0.734
2009 Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Annals of the New York Academy of Sciences. 1173: 515-20. PMID 19758194 DOI: 10.1111/J.1749-6632.2009.04656.X  0.731
2009 Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. Plos One. 4: e6635. PMID 19675671 DOI: 10.1371/Journal.Pone.0006635  0.773
2009 Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert JW, Hupperts R, Damoiseaux J. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmunity Reviews. 8: 621-6. PMID 19393206 DOI: 10.1016/J.Autrev.2009.02.009  0.755
2009 Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. Journal of Neuroimmunology. 207: 117-21. PMID 19178954 DOI: 10.1016/J.Jneuroim.2008.12.011  0.747
2008 Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1220-4. PMID 18653736 DOI: 10.1177/1352458508094399  0.746
2008 Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. Journal of Neuroimmunology. 194: 7-17. PMID 18177949 DOI: 10.1016/J.Jneuroim.2007.11.014  0.762
Show low-probability matches.